- Home
- EVAX vs NXGL Comparison
EVAX vs NXGL Comparison
Compare EVAX & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- NXGL
- Stock Information
- Founded
- EVAX 2008
- NXGL 1997
- Country
- EVAX Denmark
- NXGL United States
- Employees
- EVAX N/A
- NXGL N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- NXGL Medical/Dental Instruments
- Sector
- EVAX Health Care
- NXGL Health Care
- Exchange
- EVAX Nasdaq
- NXGL Nasdaq
- Market Cap
- EVAX 16.3M
- NXGL 18.9M
- IPO Year
- EVAX 2021
- NXGL 2021
- Fundamental
- Price
- EVAX $1.49
- NXGL $2.70
- Analyst Decision
- EVAX Strong Buy
- NXGL
- Analyst Count
- EVAX 2
- NXGL 0
- Target Price
- EVAX $10.00
- NXGL N/A
- AVG Volume (30 Days)
- EVAX 76.2K
- NXGL 36.7K
- Earning Date
- EVAX 05-27-2025
- NXGL 05-12-2025
- Dividend Yield
- EVAX N/A
- NXGL N/A
- EPS Growth
- EVAX N/A
- NXGL N/A
- EPS
- EVAX N/A
- NXGL N/A
- Revenue
- EVAX $3,344,000.00
- NXGL $8,688,000.00
- Revenue This Year
- EVAX $102.45
- NXGL $51.39
- Revenue Next Year
- EVAX $100.30
- NXGL $36.14
- P/E Ratio
- EVAX N/A
- NXGL N/A
- Revenue Growth
- EVAX 4480.82
- NXGL 112.47
- 52 Week Low
- EVAX $1.20
- NXGL $1.84
- 52 Week High
- EVAX $21.80
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- EVAX 43.19
- NXGL 46.52
- Support Level
- EVAX $1.20
- NXGL $2.54
- Resistance Level
- EVAX $1.46
- NXGL $2.99
- Average True Range (ATR)
- EVAX 0.13
- NXGL 0.26
- MACD
- EVAX 0.03
- NXGL 0.01
- Stochastic Oscillator
- EVAX 59.18
- NXGL 62.43
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.